12.10.2021 Views

Selwyn Times: October 13, 2021

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

• By Chris Barclay<br />

THE IMPACT of cannabis use<br />

among expectant mothers is<br />

the focus of ground-breaking<br />

research led by a genetics expert<br />

at Canterbury University.<br />

Funded by the Canterbury<br />

Medical Research Foundation,<br />

the year-long study aims to determine<br />

whether using the drug<br />

during pregnancy can lead to<br />

health effects already associated<br />

with tobacco.<br />

West Melton’s Dr Amy Osborne,<br />

a senior lecturer in the<br />

School of Biological Sciences, has<br />

already established that heavy<br />

cannabis use has an impact on<br />

human DNA, with the effect<br />

stronger in people who also<br />

smoke cigarettes.<br />

That research, published in<br />

May last year, has been followed<br />

by this US-inspired probe to discover<br />

if a woman’s cannabis use<br />

can alter their offspring’s DNA.<br />

“We know smoking tobacco<br />

during pregnancy is harmful,<br />

but the problem is a lot of people<br />

are using cannabis for morning<br />

sickness because they think it’s<br />

safe,” Osborne said.<br />

“In the US it’s also being<br />

used as an opioid replacement<br />

therapy for pregnant women, a<br />

replacement for hard and more<br />

illicit drugs: ‘You’re not going<br />

to do heroin while you’re<br />

pregnant, but here, have some<br />

cannabis’.”<br />

Osborne said some of the<br />

research Stateside assessing<br />

the effects of cannabis use during<br />

pregnancy revealed some<br />

behavioural impacts similar to<br />

tobacco.<br />

Her latest study, which starts<br />

this month, dovetails with DNA<br />

data already available through<br />

the Christchurch Health and Development<br />

Study, an investigation<br />

which started more than 40<br />

years ago and originally included<br />

1265 people.<br />

Osborne has already sourced<br />

DNA data from cannabis users<br />

Latest Canterbury news at starnews.co.nz<br />

among that cohort, CMRF<br />

backing worth $100,000 now<br />

enables the Londoner and two<br />

staff to access data from mothers<br />

and their offspring held at the<br />

University of Bristol in the<br />

United Kingdom.<br />

The UK data is vital because it<br />

covers DNA from the parent and<br />

their children because the CHDS<br />

information doesn’t include the<br />

parents.<br />

“We can use the UK data to inform<br />

what we’d be looking for in<br />

the New Zealand cohort. We can<br />

streamline what we’re looking<br />

for so it means we’re more likely<br />

to get a better idea of what’s happening<br />

at the molecular level,”<br />

Osborne said.<br />

“In New Zealand our sample<br />

sizes are a lot smaller so if<br />

we want to statistically show<br />

associations – and it’s all about<br />

statistical power in genetics –<br />

the more samples you have the<br />

more likely you are to detect<br />

something.”<br />

Ultimately, Osborne would<br />

like to develop a mine of information<br />

from pregnant New<br />

Zealanders.<br />

NEWS 9<br />

Expectant mums focus of cannabis use study<br />

GROUND-<br />

BREAKING: Dr<br />

Amy Osborne is<br />

able to study the<br />

effect of cannabis<br />

use by pregnant<br />

women thanks<br />

to funding from<br />

the Canterbury<br />

Medical Research<br />

Foundation.<br />

PHOTO: GEOFF<br />

SLOAN ​<br />

Wednesday <strong>October</strong> <strong>13</strong> <strong>2021</strong> <strong>Selwyn</strong> <strong>Times</strong><br />

“It would be amazing. We<br />

haven’t explored that as an option<br />

yet but depending on what<br />

we find it may be that’s naturally<br />

where our research goes. Then<br />

again that requires clinicians,<br />

epidemiologists, nurses and a lot<br />

of people recruiting as well,” she<br />

said.<br />

Osborne emphasised the study<br />

was impartial regarding cannabis.<br />

“We’re not trying to say ‘cannabis<br />

is bad for you or cannabis<br />

is good for you’. It’s really important<br />

to make the distinction<br />

that this is basic biology, basic<br />

biological research,” she said.<br />

“What we’re trying to do is understand<br />

a little bit more of the<br />

impacts it (cannabis use) might<br />

be having.<br />

“Whether that’s the detrimental<br />

impacts that come with<br />

long-term use or whether it’s<br />

the medicinal and therapeutic<br />

impacts, we just don’t know.”<br />

Osborne said while cannabis<br />

use can be detrimental for heavy<br />

users, it could be beneficial<br />

regarding pain management, the<br />

treatment of chronic illnesses<br />

and end of life care.<br />

“If we can put some<br />

empirical meat on the bone<br />

and understand a bit about the<br />

molecular pathways that may<br />

or may not be involved we can<br />

start to understand a lot more,<br />

she said.<br />

“Without doubt, it was the<br />

capital gain that sold us...<br />

..but it was more than that. The value of what we could<br />

get here - three bedrooms, a double garage,<br />

so I could have my workshop, and a small garden<br />

to keep Diane, my wife, happy...well, we just knew<br />

it was the one.”<br />

There are many more reasons why Woodcroft Estate could be<br />

the right choice for you. Why not come into our onsite office<br />

and discover just how much more there is to be gained in your<br />

retirement living.<br />

BRUCE WALLACE - RETIRED BUSINESSMAN<br />

PAVILION & SALES OFFICE OPEN BY APPOINTMENT<br />

MON-FRI 9AM TILL 3PM | CALL 0800 KARAKA TO BOOK<br />

34 KENDON DRIVE LEVI PARK, ROLLESTON | CORINNE 03 421 7796 | 021 292 1141 |<br />

SALES@WOODCROFTESTATE.CO.NZ |<br />

karakapines.co.nz

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!